Division of Vascular Surgery, Stanford University Medical Center, Stanford, Calif.
Division of Vascular Surgery, Stanford University Medical Center, Stanford, Calif.
J Vasc Surg. 2019 Feb;69(2):385-393. doi: 10.1016/j.jvs.2018.02.054. Epub 2018 Jun 28.
Endovascular aneurysm repair (EVAR) has become the standard of care for infrarenal aneurysms. Endografts are commercially available in proximal diameters up to 36 mm, allowing proximal seal in necks up to 32 mm. We sought to further investigate clinical outcomes after standard EVAR in patients requiring large main body devices.
We performed a retrospective review of a prospectively maintained database for all patients undergoing elective EVAR for infrarenal abdominal aortic aneurysms at a single institution from 2000 to 2016. Only endografts with the option of a 34- to 36-mm proximal diameter were included. Requisite patient demographics, anatomic and device-related variables, and relevant clinical outcomes and imaging were reviewed. The primary outcome in this study was proximal fixation failure, which was a composite of type IA endoleak and stent graft migration >10 mm after EVAR. Outcomes were stratified by device diameter for the large-diameter device cohort (34-36 mm) and the normal-diameter device cohort (<34 mm).
There were 500 patients treated with EVAR who met the inclusion criteria. A total of 108 (21.6%) patients received large-diameter devices. There was no difference between the large-diameter cohort and the normal-diameter cohort in terms of 30-day (0.9% vs 0.95%; P = .960) or 1-year mortality (9.0% vs 6.2%; P = .920). Proximal fixation failure occurred in 24 of 392 (6.1%) patients in the normal-diameter cohort and 26 of 108 (24%) patients in the large-diameter cohort (P < .001). There were 13 (3.3%) type IA endoleaks in the normal-diameter cohort and 16 (14.8%) in the large-diameter cohort (P < .001). Stent graft migration (>10 mm) occurred in 15 (3.8%) in the normal-diameter cohort and 16 (14.8%) in the large-diameter cohort (P < .001). After multivariate analysis, only the use of Talent (Medtronic, Minneapolis, Minn) endografts (odds ratio [OR], 4.50; 95% confidence interval [CI], 1.18-17.21) and neck diameter ≥29 mm (OR, 2.50; 95% CI, 1.12-5.08) remained significant independent risk factors for development of proximal fixation failure (OR, 3.99; 95% CI, 1.75-9.11).
Standard EVAR in patients with large infrarenal necks ≥29 mm requiring a 34- to 36-mm-diameter endograft is independently associated with an increased rate of proximal fixation failure. This group of patients should be considered for more proximal seal strategies with fenestrated or branched devices vs open repair. Also, this group likely needs more stringent radiographic follow-up.
血管内动脉瘤修复术(EVAR)已成为治疗肾下型动脉瘤的标准方法。目前市场上可提供近端直径达 36mm 的内支架移植物,可用于密封近端直径达 32mm 的颈部。本研究旨在进一步探讨在需要使用大型主体装置的患者中,进行标准 EVAR 后的临床结果。
我们对一家单中心 2000 年至 2016 年间所有接受肾下型腹主动脉瘤选择性 EVAR 治疗的患者的前瞻性维护数据库进行了回顾性分析。仅纳入近端直径可选 34-36mm 的内支架移植物。回顾必需的患者人口统计学、解剖和器械相关变量以及相关的临床结果和影像学资料。本研究的主要结局是近端固定失败,包括 EVAR 后 1 型内漏和支架移植物迁移>10mm 的复合结局。根据大型装置组(34-36mm)和正常直径装置组(<34mm)的装置直径对结果进行分层。
符合纳入标准的患者共 500 例。共有 108 例(21.6%)患者接受了大直径装置治疗。在 30 天(0.9%对 0.95%;P=0.960)或 1 年死亡率(9.0%对 6.2%;P=0.920)方面,大直径组与正常直径组之间无差异。在正常直径组中,有 24 例(6.1%)患者发生近端固定失败,而在大直径组中,有 26 例(24%)患者发生近端固定失败(P<0.001)。在正常直径组中有 13 例(3.3%)1 型内漏,而在大直径组中有 16 例(14.8%)(P<0.001)。支架移植物迁移(>10mm)在正常直径组中有 15 例(3.8%),在大直径组中有 16 例(14.8%)(P<0.001)。多变量分析后,仅 Talent(美敦力,明尼苏达州明尼阿波利斯)支架移植物的使用(比值比[OR],4.50;95%置信区间[CI],1.18-17.21)和颈部直径≥29mm(OR,2.50;95%CI,1.12-5.08)仍是近端固定失败的独立危险因素(OR,3.99;95%CI,1.75-9.11)。
在需要使用 34-36mm 直径内支架移植物的肾下颈部直径≥29mm 的患者中,标准 EVAR 与近端固定失败的发生率增加独立相关。这组患者应考虑采用血管腔内技术,如开窗或分支型支架移植物,而不是开放修复。此外,这组患者可能需要更严格的影像学随访。